Market Cap 3,000.00
Revenue (ttm) 36.94M
Net Income (ttm) -57.19M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -154.82%
Debt to Equity Ratio -0.03
Volume 158
Avg Vol 1,112
Day's Range N/A - N/A
Shares Out 32.31M
Stochastic %K 50%
Beta -0.23
Analysts Strong Buy
Price Target N/A

Company Profile

Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes SIVEXTRO, an oxazolidinone-class antibacterial for the treatment of acute bacterial skin and skin structure infection (ABSSSI); and XENLETA, a semi-synthetic pleuromutilin antibiotic for oral and IV administration. It also develops XENLETA that is in Phase I clinical trial for the treatment of pediatric...

Industry: Biotechnology
Sector: Healthcare
Phone: 610-816-6640
Address:
Alexandra House, Office 225/227 The Sweepstakes, Dublin, Ireland
BullDonald
BullDonald Sep. 5 at 11:22 AM
$PTN Like I SAW it Comming... Spana Did it. Today i did not beleive what m seeing sfor a moment .. it's OTC now... Try to get ur ur money some how... befor they dissapear. U dont want to be in a situation lilke : $NBRVF Once in OTC u are Blind whats going on behind the scene. they make money under the table and can sell everything for penny, Retail gets Nothing... BE WARNNED. Third stock that was in my Portfolio once goes.... BK.
2 · Reply
Williamstock70
Williamstock70 Sep. 5 at 10:56 AM
$NBRVF % chance that we'll have news before the end of the year?
1 · Reply
Iknowu2
Iknowu2 Aug. 23 at 4:46 PM
$NBRVF I find it difficult to believe they'll settle for nothing. Consider the accounting firm they hired, which was paid millions and has a team dedicated to this deal. That firm would never get involved with a deal that isn't worth at least $200-$250 million. Given that the company has already spent $30-$40 million since the wind-down, it's clear they aren't aiming for a meager outcome.
2 · Reply
PeonofIndustry
PeonofIndustry Aug. 12 at 1:37 AM
$NBRVF best case scenario.. what are we expecting a share?
2 · Reply
sam2680
sam2680 Aug. 8 at 6:26 PM
$NBRVF another Friday and no news.. maybe 2030? is the year now.
1 · Reply
Iknowu2
Iknowu2 Jul. 29 at 9:12 PM
$NBRVF I do not understand why they still have so many active employees (LinkedIn).Their products are gone, all inventory has been recalled, and there is nothing left. How are they paying these employees, and for what purpose? Why are they wasting whatever, if anything, is left for the shareholders?
1 · Reply
Thomasgs
Thomasgs Jul. 12 at 5:13 PM
$YOU hi I'm new here. What's the good news $SPY $AG going great. Mine stocks leading plus leaving seasonal weakness and this q should be pretty good. $NBRVF hey how much money would I made if I shorted near top ? Was the high around 3 or 4 thousand and now a penny . I need money for fun stuff so can't afford investments like that. That ted guy .... 👊
0 · Reply
sam2680
sam2680 Jul. 3 at 5:35 PM
$NBRVF so many years holding, I use to be young.
2 · Reply
Williamstock70
Williamstock70 Jun. 18 at 2:38 PM
$NBRVF and one more day without news..
1 · Reply
RollingStockChallenge
RollingStockChallenge Jun. 17 at 3:09 PM
0 · Reply
Latest News on NBRVF
No data available.
BullDonald
BullDonald Sep. 5 at 11:22 AM
$PTN Like I SAW it Comming... Spana Did it. Today i did not beleive what m seeing sfor a moment .. it's OTC now... Try to get ur ur money some how... befor they dissapear. U dont want to be in a situation lilke : $NBRVF Once in OTC u are Blind whats going on behind the scene. they make money under the table and can sell everything for penny, Retail gets Nothing... BE WARNNED. Third stock that was in my Portfolio once goes.... BK.
2 · Reply
Williamstock70
Williamstock70 Sep. 5 at 10:56 AM
$NBRVF % chance that we'll have news before the end of the year?
1 · Reply
Iknowu2
Iknowu2 Aug. 23 at 4:46 PM
$NBRVF I find it difficult to believe they'll settle for nothing. Consider the accounting firm they hired, which was paid millions and has a team dedicated to this deal. That firm would never get involved with a deal that isn't worth at least $200-$250 million. Given that the company has already spent $30-$40 million since the wind-down, it's clear they aren't aiming for a meager outcome.
2 · Reply
PeonofIndustry
PeonofIndustry Aug. 12 at 1:37 AM
$NBRVF best case scenario.. what are we expecting a share?
2 · Reply
sam2680
sam2680 Aug. 8 at 6:26 PM
$NBRVF another Friday and no news.. maybe 2030? is the year now.
1 · Reply
Iknowu2
Iknowu2 Jul. 29 at 9:12 PM
$NBRVF I do not understand why they still have so many active employees (LinkedIn).Their products are gone, all inventory has been recalled, and there is nothing left. How are they paying these employees, and for what purpose? Why are they wasting whatever, if anything, is left for the shareholders?
1 · Reply
Thomasgs
Thomasgs Jul. 12 at 5:13 PM
$YOU hi I'm new here. What's the good news $SPY $AG going great. Mine stocks leading plus leaving seasonal weakness and this q should be pretty good. $NBRVF hey how much money would I made if I shorted near top ? Was the high around 3 or 4 thousand and now a penny . I need money for fun stuff so can't afford investments like that. That ted guy .... 👊
0 · Reply
sam2680
sam2680 Jul. 3 at 5:35 PM
$NBRVF so many years holding, I use to be young.
2 · Reply
Williamstock70
Williamstock70 Jun. 18 at 2:38 PM
$NBRVF and one more day without news..
1 · Reply
RollingStockChallenge
RollingStockChallenge Jun. 17 at 3:09 PM
0 · Reply
LORDEMAN
LORDEMAN Jun. 1 at 8:46 PM
1 · Reply
AGG80
AGG80 May. 22 at 10:20 AM
2 · Reply
sam2680
sam2680 May. 19 at 3:53 PM
$PHAT they were burning a lot of money. Commend them on cost saving. $NBRVF Director named to their board. Time to pack up the bags and move on for me.
0 · Reply
AGG80
AGG80 May. 18 at 1:38 PM
$NBRVF Read the article, NBR needed for approval then everything seems finalized…. Not sure about the payment plan… That will have to be disclosed…
3 · Reply
AGG80
AGG80 May. 18 at 1:36 PM
Meitheal Pharmaceuticals Expands Specialty Biopharmaceuticals Portfolio with Acquisition of CONTEPO™ (Fosfomycin for Injection) from Nabriva Therapeutics $NBRVF https://www.meithealpharma.com/news/83
2 · Reply
sepsis74
sepsis74 May. 10 at 6:53 AM
$NBRVF looks like Meitheal acquired both Xenleta and CONTEPO rights. The fact that Nabriva hasn't declared bankruptcy yet seems to imply that there is still some value in the equity, even if it's just the possible royalties from CONTEPO.
1 · Reply
AGG80
AGG80 May. 9 at 4:18 PM
$NBRVF 2027 last payment?
1 · Reply
AGG80
AGG80 May. 7 at 11:45 PM
$NBRVF This could take years…… lol
0 · Reply
YMoney_
YMoney_ May. 7 at 7:48 PM
$NBRVF May 17th marks 10 months since the sale of contepo
1 · Reply
Williamstock70
Williamstock70 May. 7 at 9:23 AM
$NBRVF Maybe in 2026, ....or 2027, or 2028....
2 · Reply
kenbkb
kenbkb Apr. 26 at 3:17 AM
$PHAT $NBRVF stock was $18 six months ago lol
3 · Reply
NotHopeJustFacts
NotHopeJustFacts Apr. 23 at 3:10 AM
$PHAT this is the new stock to short, why ? because Theodore, the very same clown CEO that destroyed Nabriva $NBRVF, has just joined the board. With such a POS in the board, destruction is a certainty and this stock will never go up again. Thank you Theo for helping me find the next Turd. May 16th Put options smell like free $$$$
3 · Reply